Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
Credit: 2020 Innovation Center of NanoMedicine Summary: A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst ...




















